Difgen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DIFGEN PHARMS, and what generic and branded alternatives to DIFGEN PHARMS drugs are available?
DIFGEN PHARMS has five approved drugs.
Summary for Difgen Pharms
| US Patents: | 0 |
| Tradenames: | 12 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Difgen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Difgen Pharms | NICOTINE | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 074612-003 | Oct 20, 1997 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Difgen Pharms | NICOTINE | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 074612-002 | Jul 28, 2003 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Difgen Pharms | BUPRENORPHINE | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 210272-004 | Sep 23, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Difgen Pharms | CLONIDINE | clonidine | SYSTEM;TRANSDERMAL | 076157-003 | Aug 18, 2009 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
